Generated by All in One SEO v5.0.0.1, this is an llms.txt file, used by LLMs to index the site.

# Doseology Investor

Symbol CSE-MOOD

## Sitemaps

- [XML Sitemap](https://doseology.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Doseology Announces Extension to Closing of Private Placement](https://doseology.com/2026/06/29/doseology-announces-extension-to-closing-of-private-placement/) - Kelowna, British Columbia – June 29, 2026 – Doseology Sciences Inc. (CSE: MOOD |OTCQB: DOSEF | FSE: VU70) (“Doseology” or the “Company”) a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that, further to its news releases of March 30, 2026 and May 15, 2026,
- [Doseology Announces Extension to Closing of Private Placement and Resignation of Officer](https://doseology.com/2026/05/15/doseology-announces-extension-to-closing-of-private-placement-and-resignation-of-officer/) - Kelowna, British Columbia – May 15, 2026 – Doseology Sciences Inc. (CSE: MOOD |OTCQB: DOSEF | FSE: VU70) (“Doseology” or the “Company”) a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that, further to its news release of March 30, 2026, it has received a 45-day extension from the Canadian Securities Exchange to close its non-brokered private placement (the “Offering”). The Offering will consist of up to 3,225,806 units (each, a “Unit”) at a price of $0.62 per Unit to raise aggregate gross proceeds of up to $2,000,000.
- [Doseology Announces $2M Financing to Accelerate Commercialization of Oral Stimulant Pouch Platform](https://doseology.com/2026/03/30/doseology-announces-2m-financing-to-accelerate-commercialization-of-oral-stimulant-pouch-platform/) - Kelowna, British Columbia – March 30, 2026 – Doseology Sciences Inc. (CSE: MOOD | OTCQB: DOSEF | FSE: VU70) (“Doseology” or the “Company”) a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that it has arranged a non-brokered private placement of up to 3,225,806 units (each, a “Unit”) at a price of $0.62 per Unit to raise aggregate gross proceeds of up to $2,000,000 (the “Offering”).
- [Doseology Uplists to OTCQB as DOSEF, Expanding U.S. Investor Access to the Emerging Oral Stimulant Pouch Category](https://doseology.com/2026/03/11/doseology-uplists-to-otcqb-as-dosef/) - “We are pleased to expand trading access for U.S. investors through the OTCQB market,” said Chris Jackson, Chief Executive Officer of Doseology Sciences Inc. “The United States represents both the largest capital market and one of the most important consumer markets for modern oral stimulant products, and this milestone supports our long‑term growth strategy. Trading on OTCQB aligns the Company with higher standards of financial reporting and disclosure, providing greater transparency and confidence for investors as we execute our long-term growth strategy.”
- [Doseology Launches Feed That Brain Oral Stimulant Pouches in the U.S. Through Direct-to-Consumer Pilot](https://doseology.com/2026/03/04/doseology-launches-feed-that-brain-oral-stimulant-pouches-in-the-us-through-direct-to-consumer-pilot/) - Kelowna, British Columbia – March 4, 2026 – Doseology Sciences Inc. (CSE: MOOD | OTCQB: DOSEF | FSE: VU70) (“Doseology” or the “Company”) today announced the launch of the Feed That Brain®️ Energy Pouches, marking the Company’s first direct-to-consumer pilot program in the United States.
- [Doseology Appoints Larry Latowsky as Executive Chairman of the Board of Directors](https://doseology.com/2026/02/20/doseology-appoints-larry-latowsky-as-executive-chairman-of-the-board-of-directors/) - “Larry’s appointment strengthens Doseology at a critical early stage,” said Chris Jackson, CEO of Doseology Sciences Inc
- [Doseology Begins Pilot Production of Caffeine-Based Energy Pouches as Feed That Brain® Enters Oral Stimulant Format](https://doseology.com/2026/01/21/doseology-begins-pilot-production-of-caffeine-based-energy-pouches-as-feed-that-brain-enters-oral-stimulant-format/) - Kelowna, BC – January 21, 2026 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70) (“Doseology” or the “Company”) a leader in biotechnology-driven consumer products, today announced the initiation of a pilot production run of non-nicotine, caffeine-based energy pouches under its wholly owned Feed That Brain® brand.Doseology’s acquisition of Feed That Brain
- [Doseology Files Annual Information Form (AIF), Strengthening Public Disclosure Record AIF Filing Enhances Transparency and Provides Consolidated Disclosure for Investors](https://doseology.com/2026/01/16/doseology-files-annual-information-form-aif-strengthening-public-disclosure-record-aif-filing-enhances-transparency-and-provides-consolidated-disclosure-for-investors/) - Kelowna, BC – January 16, 2026 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70) (“Doseology” or the “Company”) a leader in biotechnology-driven consumer products, today announced that it has filed its Annual Information Form (“AIF”), a key Canadian public-company disclosure document, for the fiscal year ended June 30, 2025 on SEDAR+.The
- [Doseology Engages McKinney Regulatory Science Advisors to Advance Innovative Oral Pouch Product Development through Science and Regulatory Expertise](https://doseology.com/2026/01/12/doseology-engages-mckinney-regulatory-science-advisors-to-advance-innovative-oral-pouch-product-development-through-science-and-regulatory-expertise/) - Kelowna, BC – January 12, 2026 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70) (“Doseology” or the “Company”) a leader in biotechnology-driven consumer products, today announced a strategic partnership with McKinney Regulatory Science Advisors (“McKinney“), a premier FDA regulatory consulting firm specializing in nicotine and reduced-risk consumer products, to spearhead its
- [Doseology Announces Launch of Corporate Communications Program](https://doseology.com/2025/12/01/doseology-announces-launch-of-corporate-communications-program/) - Kelowna, BC – December 1, 2025 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70) (“Doseology” or the “Company”) is pleased to announce the launch of its Investor Communications Initiative, designed to strengthen disclosure practices, expand investor engagement, and support the Company’s long-term commercial and capital-markets strategy.The program includes a three (3)
- [Doseology Completes Extensive North American Diligence, Securing Strategic Manufacturing Agreement via U.S. Subsidiary Doseology USA Inc.](https://doseology.com/2025/11/13/doseology-completes-extensive-north-american-diligence-securing-strategic-manufacturing-agreement/) - Kelowna, BC – November 13, 2025 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70) (“Doseology” or the “Company”), an innovator in precision-formulated oral stimulants, is pleased to announce that its wholly owned Florida subsidiary, Doseology USA Inc., has executed a confidential manufacturing agreement with a leading North American production partner. This
- [Doseology Acquires Feed That Brain™ and Appoints Joseph Mimran as Strategic Advisor](https://doseology.com/2025/08/19/doseology-completes-acquisition-of-feed-that-brain/) - Kelowna, BC – August 19, 2025 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70) (“Doseology” or the “Company”), an innovator in precision-formulated oral stimulants, is pleased to announce that it has entered into an asset purchase and sale agreement (the “Asset Purchase Agreement”) to acquire the “Feed That Brain” division (the
- [Doseology Appoints Patrick W. Sills as Strategic Go-to-Market Advisor](https://doseology.com/2025/07/17/doseology-appoints-patrick-w-sills-as-strategic-goto-market-advisor/) - Kelowna, BC – July 17, 2025 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70) (“Doseology” or the “Company”), an innovator in precision-formulated oral stimulants, is pleased to announce the appointment of Patrick W. Sills as Strategic Go-to-Market Advisor.Mr. Sills is an experienced commercial strategist with over 15 years of leadership in
- [Doseology Targets Digital Nomads](https://doseology.com/2022/08/25/doseology-targets-digital-nomads/) - Vernon, British Columbia, August 25, 2022 – Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is pleased to announce the introduction of its new Brand Affiliate Program that focuses on digital nomads, especially digital influencers, to help drive direct-to-consumer sales.The
- [Doseology Raises $4,451,568 and Files Preliminary Non-offering Prospectus.](https://doseology.com/2021/05/13/doseology-raises-4451568-and-files-preliminary-non-offering-prospectus/) - NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATESVERNON, British Columbia, May 12, 2021 – Doseology Sciences Inc. (“Doseology” or the “Company”), a mental health and wellness company focused in the functional mushroom and psychedelic sectors, is pleased to announce the filing of a preliminary non-offering long form prospectus (the “Prospectus”) with
- [Doseology Receives Receipt for Final Prospectus and Announces Listing on the CSE](https://doseology.com/2021/11/12/doseology-receives-receipt-for-final-prospectus-and-announces-listing-on-the-cse/) - VERNON, BC, November 12, 2021 – Doseology Sciences Inc. (“Doseology” or the “Company”), a diversified life sciences company, is pleased to announce that it has obtained a receipt for its final non-offering, long form prospectus dated October 29, 2021 from the British Columbia Securities Commission.Concurrent with its prospectus filing, the Company also received approval from the
- [Doseology Receives Receipt for Final Prospectus and Amounts Listing on the CSE : MOOD](https://doseology.com/2021/12/12/doseology-receives-receipt-for-final-prospectus-and-amounts-listing-on-the-cse-mood/) - NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATESVERNON, BC, November 12, 2021 – Doseology Sciences Inc. (“Doseology” or the “Company”), a diversified life sciences company, is pleased to announce that it has obtained a receipt for its final non-offering, long form prospectus dated October 29, 2021 from the British Columbia Securities
- [Doseology Set to Trade CSE: MOOD](https://doseology.com/2021/11/15/doseology-set-to-trade-cse-mood/) - Vernon, British Columbia, November 15, 2021 – Doseology Sciences Inc. (CSE: MOOD) (“Doseology” or the “Company”) is pleased to announce that it has retained Hybrid Financial Ltd. (“Hybrid”) to provide marketing and call center services to the Company.Hybrid has agreed to comply with all applicable securities laws and the policies of the Canadian Securities Exchange (the “CSE”)
- [Doseology Prepares for Growth Phase in Psychedelic-Focused Mental Health Market, Completes Dealer’s License Application](https://doseology.com/2021/12/06/doseology-prepares-for-growth-phase-in-psychedelic-focused-mental-health-market-completes-dealers-license-application/) - Vernon, British Columbia, December 6, 2021 – In preparation for the expected growth in the psychedelic mushroom market, Doseology Sciences Inc. (CSE: MOOD) (“Doseology” or the “Company”) has submitted its application with Health Canada to become a “Licensed Dealer” under the Controlled Drugs and Substances Act (Canada).The global psychedelic drug market is expected by Data Bridge
- [Doseology Prepares to Expand Mushroom Production by Hiring Dr. Wellman-Labadie to Oversee Planned Research and Development Laboratory](https://doseology.com/2021/12/15/doseology-prepares-to-expand-mushroom-production-by-hiring-dr-wellman-labadie-to-oversee-planned-research-and-development-laboratory/) - Vernon, British Columbia, December 15, 2021 – Doseology Sciences Inc. (CSE: MOOD) (“Doseology” or the “Company”), a British Columbia-based diversified life sciences company with plans to develop mental health therapies using natural psilocybin treatments, formally announces the addition of Dr. Wellman-Labadie to its growing team of mycologists and researchers.Dr. Olivier Wellman-Labadie, Ph.D. has been serving as an Advisor to Doseology
- [Investor Year End Update](https://doseology.com/2021/12/31/investor-year-end-update/) - With the end of another year at hand, the Doseology family is reflecting on recent achievements and sharing our ambitious plans for 2022.First of all, we are deeply grateful for your support. This year especially, everyone has been touched in some way by personal wellness or mental health challenges. Change and innovation are now happening
- [Doseology Completes Development and Test Marketing of Adaptogenic Mushroom Product Line](https://doseology.com/2022/01/06/doseology-completes-development-and-test-marketing-of-adaptogenic-mushroom-product-line/) - Vernon, British Columbia, January 6, 2022 – Doseology Sciences Inc. (CSE: MOOD) (“Doseology” or the “Company”), a British Columbia-based diversified life sciences company developing mushroom-based health and wellness solutions, announces the successful soft launch of seven new adaptogenic mushroom products in the United States, and the upcoming launch of the product line in the Canadian market during the first quarter
- [Doseology Launches Medicinal Mushroom Product Line in Canada to Supply Increasing Demand](https://doseology.com/2022/02/23/doseology-launches-medicinal-mushroom-product-line-in-canada-to-supply-increasing-demand/) - Vernon, British Columbia, February 23, 2022 – Doseology Sciences Inc. (CSE: MOOD) (“Doseology” or the “Company”), a British Columbia-based diversified life sciences company developing mushroom-based health and wellness solutions, announces the launch of its Health Canada NPN-approved medicinal mushroom product line in Canada, and preparation for a national multichannel marketing campaign.About the Doseology Product LineThe Canadian product line includes five
- [Doseology Names CFO and Appoints New Board Member](https://doseology.com/2022/01/28/doseology-names-cfo-and-appoints-new-board-member/) - Vernon, British Columbia, January 28, 2022 – Doseology Sciences Inc. (CSE: MOOD) (“Doseology” or the “Company”), a British Columbia-based diversified life sciences company developing mushroom-based health and wellness solutions, announces the appointment of Peter Geh as Chief Financial Officer, effective January 26, 2022, and the addition of Harbir Toor as Director and Independent Audit Chair, effective January 27, 2022.Peter Geh is
- [Doseology Appoints Maryam Marissen as CEO to Prepare for Next Growth Stage](https://doseology.com/2022/01/13/doseology-appoints-maryam-marissen-as-ceo-to-prepare-for-next-growth-stage/) - Vernon, British Columbia, January 13, 2022 – Doseology Sciences Inc. (CSE: MOOD) (“Doseology” or the “Company”) announces the appointment of Maryam Marissen as Chief Executive Officer and Director, effective immediately. Outgoing interim CEO and co-founder Daniel Vice will remain involved with the Company as an independent director. Doseology is a British Columbia-based, diversified life sciences company developing mushroom-based health and wellness
- [Doseology Announces Management Change](https://doseology.com/2022/03/02/doseology-announces-management-change/) - Vernon, British Columbia, March 2, 2022 – Doseology Sciences Inc. (CSE: MOOD) (“Doseology” or the “Company”) announces the departure of Maryam Marissen as Chief Executive Officer of the Company, effective immediately.Ralph Olson, Chairman of the Company’s board of directors, stated “The Board would like to express its appreciation for Maryam’s services to the Company and wishes her well
- [Doseology Initiates Canadian Retail Sales Strategy Coast to Coast Signing with Connect Brand Management](https://doseology.com/2022/03/03/doseology-initiates-canadian-retail-sales-strategy-coast-to-coast-signing-with-connect-brand-management/) - Vernon, British Columbia, March 3, 2022 – Doseology Sciences Inc. (CSE: MOOD) (“Doseology” or the “Company”) is excited to announce it has signed a Brand and Product Representation Agreement with Connect Brand Management, a national CPG firm specializing in sales and marketing for leading natural food and nutraceutical brands, to accelerate the Company’s revenue and product rollout in
- [Doseology Announces Frankfurt Stock Exchange Quotation](https://doseology.com/2022/03/17/doseology-announces-frankfurt-stock-exchange-quotation/) - Vernon, British Columbia, March 17, 2022 – Doseology Sciences Inc. (CSE: MOOD) (FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is pleased to announce its common shares have commenced listing on the Frankfurt Stock Exchange (“FSE”) under the trading symbol VU7 (V/U/Seven) today.“We are pleased to be listed on the Frankfurt Stock Exchange
- [Doseology Accelerates Rollout of Medicinal Mushroom Products with National Distribution](https://doseology.com/2022/04/22/doseology-accelerates-rollout-of-medicinal-mushroom-products-with-national-distribution/) - Vernon, British Columbia, April 22, 2022 – Doseology Sciences Inc. (CSE: MOOD) (FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is excited to announce it has signed a Distribution Agreement with Peak Performance Products Inc. (“Peak”) for the distribution of the Company’s medicinal mushroom products across Canada.About Peak Performance Products
- [Doseology Opens to American Investors](https://doseology.com/2022/06/01/doseology-opens-to-american-investors/) - Vernon, British Columbia, June 1, 2022 – Doseology Sciences Inc. (CSE: MOOD) (FSE: VU7) (OTC: DOSEF) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is pleased to announce that its common shares (the “Shares”) were approved for trading on the OTC Pink Open Market in the United States under the symbol “DOSEF”. The Shares will continue
- [Doseology Uplists to OTCQB Market in USA](https://doseology.com/2022/07/06/doseology-uplists-to-otcqb-market-in-usa/) - Vernon, British Columbia, July 6, 2022 – Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is pleased to announce the approval of its application for an uplisting to the OTCQB Venture Market (“OTCQB”) in the United States. The Company’s common shares (the “Shares”) will commence trading on the OTCQB
- [Doseology Products Now Available on Retail Shelves](https://doseology.com/2022/08/04/doseology-products-now-available-on-retail-shelves-2/) - Vernon, British Columbia, August 4, 2022 – Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is excited to announce the Company’s functional mushroom products are now on the shelves of three Canadian retailers: City Avenue Market, Vita Health Fresh Market,
- [Doseology To Attend CHFA NOW Show, Sept 17-18](https://doseology.com/2022/09/13/doseology-to-attend-chfa-now-show-sept-17-18/) - Vernon, British Columbia, September 12, 2022 – Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is excited to announce that it is attending the CHFA NOW trade show in Toronto from September 17 to 18.CHFA NOW (chfanow.ca) is a Canadian
- [Doseology Launches in 31 Healthy Planet Locations Across Ontario](https://doseology.com/2022/10/11/doseology-launches-in-31-healthy-planet-locations-across-ontario/) - Vernon, British Columbia, October 11, 2022 – Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is excited to announce that the Company’s brand of functional mushroom products is launching in all 31 Healthy Planet retail locations across Ontario, and on
- [Doseology Expands into National Retailer Sobeys](https://doseology.com/2022/11/23/doseology-expands-into-national-retailer-sobeys/) - Vernon, British Columbia, November 23, 2022 – Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is pleased to announce that its line of functional mushroom supplements is launching in 48 Sobeys stores across Canada.The placement includes 32 locations under the
- [Doseology Goes National with Whole Foods Market](https://doseology.com/2022/11/25/doseology-goes-national-with-whole-foods-market/) - Vernon, British Columbia, November 25, 2022 – Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is excited to announce that its functional mushroom supplements will soon be available nationally at all 14 top-tier Whole Foods Market Canada locations.The Company has
- [Doseology Provides Corporate Update](https://doseology.com/2023/01/23/doseology-provides-corporate-update/) - Vernon, British Columbia, January 23, 2023 – Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, today announced that it has terminated the lease at its facility in Vernon, British Columbia. The facility, located at 6294 Old Kamloops Road, was the
- [Doseology Announces CEO Transition](https://doseology.com/2023/03/31/doseology-announces-ceo-transition/) - Kelowna, British Columbia, March 31, 2023 – Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, announces the resignation of Ralph Olson as Chief Executive Officer and Director of the Company. Pratik (Tiki) Patel has been appointed interim CEO.Mr. Patel is
- [Doseology Grows Canadian Retail Sales with Loblaw Companies](https://doseology.com/2023/09/28/doseology-grows-canadian-retail-sales-with-loblaw-companies/) - Kelowna, British Columbia, Sept. 28, 2023 – Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (“Doseology” or the “Company”), Doseology, an innovator in functional mushroom wellness products, is delighted to announce the nationwide availability of its acclaimed Mushroom Tincture Line, featuring best sellers WAKE and SLEEP stacked formulas now sold in 150+ Loblaw locations.
- [Executive Realignment at Doseology to Drive Future Expansion](https://doseology.com/2024/09/12/executive-realignment-at-doseology-to-drive-future-expansion/) - *Kelowna, British Columbia, September 12, 2024* – Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (“Doseology” or the “Company”), an innovator in functional mushroom supplements, is pleased to announce key leadership appointments and a major expansion in its retail presence. Christopher P. Cherry has been appointed Interim CEO while maintaining his role as CFO,
- [Doseology Invests into the Multi-Billion-Dollar U.S. Modern Oral Stimulant Market](https://doseology.com/2025/03/04/doseology-invests-into-the-multi-billion-dollar-u-s-modern-oral-stimulant-market/) - Kelowna, BC – March 4, 2025 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU7) (“Doseology” or the “Company”), an innovator in precision-formulated performance solutions, is pleased to announce the launch of Doseology USA Inc., a wholly owned subsidiary based in Florida. This strategic expansion marks Doseology’s official entry into the multi-billion-dollar
- [Doseology Appoints Chris Jackson, Founder of Qtrade, as Chief Executive Officer and a Director](https://doseology.com/2025/04/25/doseology-appoints-chris-jackson-founder-of-qtrade-as-chief-executive-officer-and-a-director/) - Kelowna, BC – April 25, 2025 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU7) (“Doseology” or the “Company”), an innovator in precision-formulated performance solutions, is pleased to announce the appointment of Chris Jackson as its new Chief Executive Officer and a member of its board of directors, effective May 1, 2025. Mr.
- [Doseology Announces $1.2M Private Placement to Advance Commercialization](https://doseology.com/2025/04/28/doseology-announces-1-2m-private-placement-to-advance-commercialization/) - Kelowna, BC – April 28, 2025 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU7) (“Doseology” or the “Company”), an innovator in precision-formulated performance solutions, is pleased to announce a non-brokered private placement of up to 10,000,000 units (each a “Unit”) at $0.12 per Unit for gross proceeds of up to $1,200,000
- [Doseology Announces Amended Private Placement Unit Price](https://doseology.com/2025/05/23/doseology-announces-amended-private-placement-unit-price/) - Kelowna, BC – May 23, 2025 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU7) (“Doseology” or the “Company”), an innovator in precision-formulated performance solutions, announces that, further to its news release of April 28, 2025, it has amended the unit (each a “Unit”) price of its non-brokered private placement (the “Private
- [Doseology Announces Option Grant](https://doseology.com/2025/05/01/doseology-announces-option-grant/) - Kelowna, BC – May 1, 2025 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU7) (“Doseology” or the “Company”), an innovator in precision-formulated performance solutions, announces it has granted 155,000 incentive stock options (“Options”) to Chris Jackson, the Company’s new CEO and member of the board of directors. The Options are exercisable
- [Doseology Closes $750,000 Non-Brokered Private Placement](https://doseology.com/2025/06/12/doseology-closes-750000-non-brokered-private-placement/) - Kelowna, BC – June 12, 2025 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70) (“Doseology” or the “Company”), an innovator in precision-formulated performance solutions, is pleased to announce that it has closed its previously announced non-brokered private placement of 3,336,106 units of the Company (“Units”) at a price of $0.225 per
- [Doseology Appoints Timothy Corkum as President & COO to Drive Strategic Expansion into the Stimulant Pouch Market](https://doseology.com/2025/06/17/doseology-appoints-timothy-corkum-as-president-coo-to-drive-strategic-expansion-into-the-stimulant-pouch-market/) - Kelowna, BC – June 17, 2025 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70) (“Doseology” or the “Company”), an innovator in precision-formulated oral stimulants, is pleased to announce the appointment of Mr. Timothy Corkum as President and Chief Operating Officer, effective immediately.Mr. Corkum brings over 20 years of executive leadership experience
- [Doseology Expands into US Retail Market](https://doseology.com/2022/07/14/doseology-expands-into-us-retail-market/) - Vernon, British Columbia, July 14, 2022 – Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is excited to announce it has signed a Sales Management Agreement with Alternative Sales Management to act as the Company’s national sales manager for its
- [Doseology Welcomes New CFO](https://doseology.com/2023/03/03/doseology-welcomes-new-cfo/) - Kelowna, British Columbia, March 3, 2023 – Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is pleased to announce the appointment of Pratik (Tiki) Patel as Chief Financial Officer of the Company.Mr. Patel replaces Peter Geh as CFO. The Company
- [Doseology Appoints New CFO and Expands Distribution Reach](https://doseology.com/2024/05/13/doseology-appoints-new-cfo-and-expands-distribution-reach/) - Kelowna, British Columbia, May 13, 2024 – Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (“Doseology” or the “Company”), Doseology, an innovator in functional mushroom wellness products, is thrilled to announce the appointment of Christopher P. Cherry as CFO of the Company. Mr. Cherry joins us at a pivotal moment as Doseology accelerates its

## Pages

- [Home](https://doseology.com/) - Learn how Doseology is building a performance-focused, smoke-free oral pouch platform positioned to capture global demand and deliver investor value.
- [Investors](https://doseology.com/investors/) - The global shift toward smoke-free, performance-driven stimulation is accelerating. OVERVIEW Doseology Sciences Inc. (CSE: MOOD) is one of the first Canadian small-cap pure plays in the fast-growing oral stimulant pouch category. Anchored in nicotine innovation and high-performance energy formulations, Doseology is positioned to capture early market share in a global industry projected to exceed $25
- [Contact](https://doseology.com/contact/) - CONTACT US Your Name Your Email Phone Number Service Type Message SUBMIT
- [About](https://doseology.com/about/) - OUR APPROACH Three Tracks Driving Growth, Innovation & Shareholder Value. Track 1 — Immediate Revenue Early commercialization of functional energy pouches.Targets fast-growing performance and wellness consumers.Builds early revenue traction and brand visibility. Track 2 — Fast Innovation Nootropic and energy pouch formulations ready for scale.Proprietary delivery systems engineered for efficacy and margin growth.Positioned for licensing,
- [About - BACK](https://doseology.com/about_back/) - ABOUT DOSEOLOGY OUR MISSION Our mission is to redefine the stimulant experience through safer, science-backed alternatives—empowering consumers to perform at their best while supporting global smoke-free adoption. OUR APPROACH A Three-Track Strategy Driving Revenue, Innovation, and Category Expansion TRACK 1Delivers near-term revenue through the acquisition of Feed That Brain, a functional wellness brand with retail
- [Privacy Policy](https://doseology.com/privacy-policy/) - PRIVACY POLICY Effective Date: November 1, 2025 Last Updated: November 5, 2025 1. Introduction Welcome to Doseology. At Doseology (“we”, “us”, “our”), we are committed to protecting and respecting your privacy in compliance with British Columbia’s Personal Information Protection Act (PIPA) and, where applicable, Canada’s Personal Information Protection and Electronic Documents Act (PIPEDA). This
- [PLACEHOLDER - Coming Soon](https://doseology.com/placeholder/) - The Future of Performance Pouches is Coming Soon Doseology (CSE: MOOD) is building the next generation of science-backed performance pouches—precision oral stimulants that boost energy, sharpen focus, and enhance cognition.Performance pouches are the fastest-growing format in consumer stimulants. Leveraging biotechnology and advanced formulation, Doseology is pioneering this category with scalable, precision-engineered products. CSE: MOOD |
- [Global Styles](https://doseology.com/global-styles/) - Global Styles Colors Fonts buttons This page previews Global Fonts and Colors for this Kit. Changes made in Site Settings will be displayed here. Global Colors SYSTEM Primary Secondary Body text accent custom BG kIt Blue Element Blue Light BG White Element Transparent Overlay bg Global Fonts SYSTEM Primaryabcd Secondaryabcd body textLooking to change global

## Categories

- [News](https://doseology.com/category/news/)